TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
TRVI

Trevi Therapeutics Inc

Healthcare · Biotechnology

14.40$ -1.8% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Cash Flow

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow TRVI
Line item 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-0.69 -0.89 -2.04 -1.29 -1.61 -1.27 -0.44 -0.32 -0.38 -0.29
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
0.00 0.02 0.06 0.06 0.13 0.11 0.04 0.02 0.04 0.04
0.01 0.22 0.31 0.08 0.13 0.12 0.04 – – –
-0.09 0.08 -0.06 0.09 0.06 0.07 -0.02 -0.04 0.07 -0.02
0.00 0.00 0.02 0.00 0.00 0.01 0.00 0.00 0.00 0.00
0.00 0.00 -0.02 0.00 0.00 -4.70 -1.66 0.60 -0.21 -0.65
0.00 0.00 0.00 0.13 – – – – – –
0.00 3.34 -0.17 -0.07 -0.02 – 1.82 – – –
0.53 -0.92 -0.54 0.78 0.78 -0.26 -0.09 -0.10 0.00 0.00
0.53 2.42 0.00 4.11 0.93 0.91 1.72 -0.08 0.61 0.83
-0.16 1.53 -1.65 2.81 -0.68 -0.36 -0.38 0.20 0.02 -0.10
-0.69 -0.89 -2.06 -1.30 -1.61 -1.27 -0.44 -0.32 -0.38 -0.29

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?